Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Nihon Chouzai Co's enterprise value is $2,796,886,942 Mil.
Nihon Chouzai Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 was $46 Mil. Therefore, Nihon Chouzai Co's EV-to-EBITDA for today is 61,385,048.00.
The historical rank and industry rank for Nihon Chouzai Co's EV-to-EBITDA or its related term are showing as below:
NHCZF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.52 Med: 11.16 Max: 29.94
Current: 23.55
During the past 13 years, the highest EV-to-EBITDA of Nihon Chouzai Co was 29.94. The lowest was 6.52. And the median was 11.16.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Nihon Chouzai Co (OTCPK:NHCZF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Nihon Chouzai Co's PE Ratio (TTM) for today is calculated as:
Nihon Chouzai Co's share price for today is $16.021923.
Nihon Chouzai Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.260.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Nihon Chouzai Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nihon Chouzai Co EV-to-EBITDA Competitor Comparison
For the Pharmaceutical Retailers subindustry, Nihon Chouzai Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nihon Chouzai Co EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nihon Chouzai Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Nihon Chouzai Co's EV-to-EBITDA falls into.
Nihon Chouzai Co's current Enterprise Value is $2,796,886,942 Mil.
Nihon Chouzai Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $46 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nihon Chouzai Co (NHCZF) has a EV-to-EBITDA of 61,385,048.00 as of Aug. 07, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Nihon Chouzai Co. This is 550045133% above median its historical median of 11.16. Over the past decade, Nihon Chouzai Co's EV-to-EBITDA has ranged from 6.52 to 29.94.
Is Nihon Chouzai Co's EV-to-EBITDA too high?
Nihon Chouzai Co's current EV-to-EBITDA of 61,385,048.00 is 550045133% above median its 10-year median of 11.16. Over the past 10 years, this metric has ranged from a low of 6.52 to a high of 29.94. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.92. Nihon Chouzai Co's value of 61,385,048.00 is 562134039.2% above this industry median. Overall, Nihon Chouzai Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Nihon Chouzai Co's EV-to-EBITDA compare to competitors?
Nihon Chouzai Co's EV-to-EBITDA of 61,385,048.00 can be compared against companies in the Healthcare Providers & Services industry. The industry median EV-to-EBITDA is 10.92. Nihon Chouzai Co's value of 61,385,048.00 is 562134039.2% above this benchmark. Historically, Nihon Chouzai Co's own EV-to-EBITDA has ranged from 6.52 to 29.94 over the past decade. While the company's 10-year median is 11.16 vs. the industry median of 10.92, Nihon Chouzai Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.92, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nihon Chouzai Co's current EV-to-EBITDA of 61,385,048.00 is 562134039.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Nihon Chouzai Co. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nihon Chouzai Co's current EV-to-EBITDA is 61,385,048.00, which is 550045133% above median its own 10-year median of 11.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nihon Chouzai Co stock overvalued right now?
Nihon Chouzai Co (NHCZF) has a current EV-to-EBITDA of 61,385,048.00. The stock's GF Value™ is $6.38, compared to a current price of $16.02 — trading 151.1% above its estimated fair value. The current EV-to-EBITDA is 61,385,048.00, which is 550045133% above median its 10-year median of 11.16 and 562134039.2% above the Healthcare Providers & Services industry median of 10.92. Nihon Chouzai Co's overall GF Score™ is 9/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Nihon Chouzai Co (NHCZF), the current EV-to-EBITDA is 61,385,048.00 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nihon Chouzai Co (NHCZF) Overvalued in 2026?
Based on GuruFocus' analysis, Nihon Chouzai Co stock appears to be overvalued.
The current stock price of $16.02 is trading 151.1% above its estimated GF Value™ of $6.38.
Key valuation signals for NHCZF:
EV-to-EBITDA: 61,385,048.00 (550045133% above median its 10-year median of 11.16)
GF Value™: $6.38 vs. price of $16.02 (151.1% above fair value)
Industry Position: 562134039.2% above the Healthcare Providers & Services median
No single metric tells the full story. See the NHCZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nihon Chouzai Co Ltd operates in the pharmaceutical industry. The company is organized into segments: Pharmacy, Pharmaceutical Manufacturing and Sales, and Healthcare Staffing Services and operates mainly from Japan. Through its operating segments, the firm manages a chain of pharmacies nationwide, manufactures and sells generic drugs, and provides staffing services that are specialized in pharmacy.
9GF Score
Get the complete analysis for NHCZF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NHCZF has been successfully added to your 
